| Financial Year |
March 31 2023 |
| Monetary Funds |
1,152,689,044.84 |
| Held-for-trading Financial Assets |
160,898,844.56 |
| Notes Receivable |
-- |
| Accounts Receivable |
589,045,626.35 |
| Advances to Suppliers |
15,666,286.14 |
| Other Receivables |
31,977,679.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
86,144,614.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,192,870.48 |
| Total Current Assets |
3,915,116,034.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
51,823,008.12 |
| Investment Properties |
28,636,607.29 |
| Fixed Assetes |
7,986,846,562.55 |
| Under-construction Projects |
89,684,045.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
769,955,838.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
59,485,211.14 |
| Deferred Income Tax Assets |
90,482,169.41 |
| Other Non-Current Assets |
255,893,697.41 |
| Sub-Total of Non-Current Assets |
9,545,419,588.11 |
| Total Assets |
13,460,535,622.49 |
| Short-Term Loans |
696,505,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
35,490,000.00 |
| Accounts Payable |
1,921,627,766.76 |
| Accounts Received In Advance |
130,814.36 |
| Employee Compensation Payable |
131,648,909.89 |
| Taxes Payable |
19,198,441.80 |
| Interest Payable |
-- |
| Dividend Payable |
1,209,363.18 |
| Other payables |
320,808,702.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
484,928,766.61 |
| Other Current Liabilities |
160,006,192.66 |
| Sub-Total of Current Liabilities |
5,744,587,767.88 |
| Long-term Loans |
3,542,183,233.48 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
99,597.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,188,000.00 |
| Deferred Income Tax Liabilities |
1,200,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,552,032,952.38 |
| Total Liabilities |
9,296,620,720.26 |
| Paid-In Capital(Or Share Stock) |
2,275,255,232.00 |
| Capital Surplus |
1,093,370,784.48 |
| Surplus Reserve |
400,702,384.75 |
| LESS:Treasury Stock |
152,253,592.61 |
| Undistributed Profits |
567,720,158.30 |
| Minority Stockholder's Interest |
-20,880,064.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,184,794,966.92 |
| Owner's Equity（Stockholder's Equity） |
4,163,914,902.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,460,535,622.49 |
